Skip to main navigation Skip to search Skip to main content

Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial

Project: Research

Project Details

StatusFinished
Effective start/end date02/14/1310/24/14

Funding

  • Jewish General Hospital McGill University: $8,795.30